Acceptance and commitment therapy applied to treatment of auditory hallucinations

Clinical Case Studies

Volumn 7, Issue 2, 2008, Pages 118-135

  Veiga Martínez, Carlos ^a   Pérez Álvarez, Marino ^b   García Montes, José M ^c  

^a Principado de Asturias Health Service   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Acceptance and commitment therapy; Auditory hallucinations; Hearing voices

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; FLUOXETINE; LORAZEPAM; NEUROLEPTIC AGENT;

ACCEPTANCE AND COMMITMENT THERAPY; ADULT; AUDITORY HALLUCINATION; AVOIDANCE BEHAVIOR; CASE REPORT; COGNITIVE THERAPY; HUMAN; MALE; MENTAL HEALTH CENTER; PSYCHOLOGIST; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT INDICATION;

EID: 40849135771     PISSN: 15346501     EISSN: 15523802     Source Type: Journal    
DOI: 10.1177/1534650107306291     Document Type: Review

References (34)

1. Bach, P.A., Gaudiano, B., Pankey, J., Herbert, J.D., & Hayes, S.C. (2006). Acceptance, mindfulness, values, and psychosis: Applying acceptance and commitment therapy (ACT) to the chronically mentally ill. In R. A. Baer (Ed.), Mindfulness-based treatment approaches: Clinician's guide to evidence base and applications (pp. 93-116). Amsterdam: Academic Press.
2. Bach, P.A., & Hayes, S.C. (2002). The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 70 (5). 1129-1139.
3. Batten, S., & Hayes, S.C. (2005). Acceptance and commitment therapy in the treatment of comorbid substance abuse and post-traumatic stress disorder. Clinical Case Studies, 4, 246-262.
4. Burlingame, G., Seaman, S., Johnson, J., Whipple, J., & Richardson, E. (2006). Sensitivity to change of the Brief Psychiatric Rating Scale-Extended (BPRS-E): An item and subscale analysis. Psychological Services, 3, 77-87.
5. Cather, C., Penn, D., Otto, M.W., Yovel, I., Mueser, K.T., & Goff, D.C. (2005). A pilot study of functional cognitive behavioural therapy (fCBT) for schizophrenia. Schizophrenia Research, 74, 201-209.
6. Chadwick, P. (2006). Person-based cognitive therapy for distressing psychosis. Chichester, UK: Wiley.
7. Chadwick, P., Birchwood, M., & Trower, P. (1996). Cognitive therapy for delusions, voices and paranoia. Chichester, UK: Wiley.
8. Dimidjian, S., Hollon, S.D., Dobson, K.S., Schmaling, K.B., Kohlenberg, R.J., Addis, M.E., et al. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults. Journal of Consulting and Clinical Psychology, 74 (4). 658-670.
9. El-Sayeh, H.G., Morganti, C., & Adams, C.E. (2006). Aripiprazole for schizophrenia: Systematic review. British Journal of Psychiatry, 189, 102-108.
10. Freeman, D., & Garety, P.A. (2003). Connecting neurosis and psychosis: The direct influence of emotion on delusions and hallucinations. Behaviour Research and Therapy, 41, 923-947.
11. García-Montes, J.M., Luciano, M.C., Hernández, M., & Zaldivar, F. (2004). Aplicación de la Terapia de Aceptación y Compromiso (ACT) en sintomatología delirante: Un estudio de caso [Application of acceptance and commitment therapy (ACT) in delusional symptomatology: A case study]. Psicothema, 16, 117-124.
12. García-Montes, J.M., & Pérez-Álvarez, M. (2001). ACT como tratamiento de síntomas psicóticos. El caso de las alucinaciones auditivas [ACT as a treatment for psychotic symptoms: The case of auditory hallucinations]. Análisis y Modificación de Conducta, 27 (113). 455-472.
13. García-Montes, J.M., & Pérez-Álvarez, M. (in press). Exposition in existential terms of a case of "negative schizophrenia" approached by means of acceptance and commitment therapy. International Journal of Existential Psychology and Psychotherapy.
14. Gaudiano, B.A. (2005). Cognitive behavior therapies for psychotic disorders: Current empirical status and future directions. Clinical Psychology: Science and Practice, 12, 33-50.
15. Gaudiano, B.A. (2006 a). The cognitive-behavioral treatment of schizophrenia: The state of the art and the evidence. International Journal of Behavioral and Consultation Therapy, 2, 1-11.
16. Gaudiano, B.A. (2006 b). Is symptomatic improvement in clinical trials of cognitive-behavioral therapy for psychosis clinically significant ? Journal of Psychiatric Practices, 12, 11-23.
17. Gaudiano, B.A., & Herbert, J.D. (2006). Acute treatment of inpatients with psychotic symptoms using acceptance and commitment therapy: Pilot results. Behaviour Research and Therapy, 44, 415-437.
18. Hayes, S.C. (2004). Acceptance and commitment therapy, relational frame theory, and the third wave of behaviour therapy. Behavior Therapy, 35, 638-665.
19. Hayes, S.C., Batten, S., Gifford, E., Wilson, K., Afairi, N., & McCurry, S. (1999). Acceptance and commitment therapy: An individual psychotherapy manual for the treatment of experiential avoidance. Reno, NV: Context Press.
20. Hayes, S. C., & Strosahl, K. D. (Eds.). (2004). A practical guide to acceptance and commitment therapy. New York: Springer.
21. Hayes, S.C., Strosahl, K.D., & Wilson, K.G. (1999). Acceptance and commitment therapy. New Cork: Guilford.
22. Hopko, D.R., Lejuez, C.W., Ruggiero, K.J., & Eifert, G.H. (2003). Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clinical Psychology Review, 23, 699-717.
23. Kapur, S. (2003). Psychosis as state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry, 160, 13-23.
24. Kingdon, D.G., & Turkington, D. (1994). Cognitive-behavioural therapy of schizophrenia. New York: Guilford.
25. Lacro, J.P., Dunn, L.B., Dolder, C.R., Leckband, S.G., & Jeste, D.V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892-909.
26. Lieberman, J.A., Stroup, T.S., McEvey, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209-1223.
27. Lukoff, P., Nuechterlein, K.H., & Ventura, J. (1986). Manual for the expanded Brief Psychiatric Research Scale. Schizophrenia Bulletin, 1, 594-602.
28. Maher, B.A. (1988). Anomalous experience and delusional thinking. In T. F. Oltmanns & B. A. Maher (Eds.), Delusional beliefs (pp. 15-33). New York: Wiley.
29. Mueser, K.T., Curran, P.J., & McHugo, G.J. (1997). Factor structure of Brief Psychiatric Rating Scale in schizophrenia. Psychological Assessment, 9, 196-204.
30. Perona-Garcelán, S., Cuevas-Yust, C., Vallina-Fernández, O., & Lemos-Giráldez, S. (2003). Terapia Cognitivo-Conductual de la Esquizofrenia: Guía Clínica [Cognitive-behavioral therapy for schizophrenia: A clinical guide]. Madrid, Spain: Minerva.
31. Romme, M., & Escher, S. (2000). Making sense of voices: The mental health professional's guide to working with voice-hearers. London: Mind.
32. Seikkula, J., & Olson, M.E. (2003). The open dialogue approach to acute psychosis: Its poetics and micropolitics. Family Process, 42, 403-418.
33. Temple, S. (2004). Cognitive therapy for auditory hallucinations in schizophrenia. Journal of Cognitive Psychotherapy: An International Quarterly, 18, 223-236.
34. Wilson, K.G., & Luciano, M.C. (2002). Terapia de Aceptación y Compromiso (ACT): Un tratamiento conductual orientado a valores [Acceptance and commitment therapy (ACT): A behavioral treatment focused on values]. Madrid, Spain: Pirámide.